Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study-Reference-Cited by-同舟云学术

Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study

Published:2022-05 Issue:5 Volume:9 Page:e350-e360
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Lachowiez Curtis A,Reville Patrick K,Kantarjian Hagop,Jabbour Elias,Borthakur Gautam,Daver Naval,Loghavi Sanam,Furudate Ken,Xiao Lianchun,Pierce Sherry,Short Nicholas J,Maiti Abhishek,Yilmaz Musa,Sasaki Koji,Takahashi Koichi,Konopleva Marina,Pemmaraju Naveen,Popat Uday,Shpall Elizabeth,Garcia-Manero Guillermo,Ravandi Farhad,DiNardo Courtney D,Kadia Tapan M

Publisher

Elsevier BV

Subject

Hematology

Reference33 articles.

1. Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B;Rai;Blood,1981

2. Anthracycline dose intensification in acute myeloid leukemia;Fernandez;N Engl J Med,2009

3. Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study;Ohtake;Blood,2011

4. A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients;Burnett;Blood,2015

5. Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study;Holowiecki;J Clin Oncol,2012

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the role of long non-coding RNAs in therapeutic resistance in acute myeloid leukemia: New prospects & challenges;Non-coding RNA Research;2024-12

2. Recent advances in AML with mutated NPM1;International Journal of Hematology;2024-08-22

3. Effects of different conditioning regimens on HLA-mismatched microtransplantation and changes in fine immune indices in acute myeloid leukaemia;Scientific Reports;2024-08-20

4. Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease;British Journal of Haematology;2024-05-09

5. Venetoclax combined chemotherapy versus chemotherapy alone for acute myeloid leukemia: a systematic review and meta-analysis;Frontiers in Oncology;2024-03-26